
Sign up to save your podcasts
Or
Dr Ajaz is a Specialist Hepatologist and a Lifestyle Medicine Physician, and her work intersects clinical medicine and research within the Institute of Liver Studies at King’s College Hospital. She is also an Honorary Senior Clinical Lecturer at the School of Immunology and Microbial Sciences.She established the LIVFIT group, the UK’s first patient support group for metabolic dysfunction- associated steatotic liver disease ( MASLD), where lifestyle medicine is a key part of improving cardio-metabolic health, through nutrition, exercise and social connection.In this fascinating discussion you will learn all about MASLD, previously named non-alcoholic fatty liver disease. We talk about why the name changed, how prevalent the condition is, how it is diagnosed and what treatment options are available.So whether you are a clinician, or a patient with a metabolic health condition, or just curious about improving your health and preventing common conditions related to metabolic dysfunction then this episode is for you.To connect with Dr Ajaz and LIVFIT follow these links:https://www.kch.nhs.uk/about/get-involved/groups-and-events/livfit/https://www.linkedin.com/in/saima-ajaz/?originalSubdomain=ukFurther information:https://www.journal-of-hepatology.eu/article/S0168-8278(24)00329-5/fulltextTo send us an email :[email protected]
5
1515 ratings
Dr Ajaz is a Specialist Hepatologist and a Lifestyle Medicine Physician, and her work intersects clinical medicine and research within the Institute of Liver Studies at King’s College Hospital. She is also an Honorary Senior Clinical Lecturer at the School of Immunology and Microbial Sciences.She established the LIVFIT group, the UK’s first patient support group for metabolic dysfunction- associated steatotic liver disease ( MASLD), where lifestyle medicine is a key part of improving cardio-metabolic health, through nutrition, exercise and social connection.In this fascinating discussion you will learn all about MASLD, previously named non-alcoholic fatty liver disease. We talk about why the name changed, how prevalent the condition is, how it is diagnosed and what treatment options are available.So whether you are a clinician, or a patient with a metabolic health condition, or just curious about improving your health and preventing common conditions related to metabolic dysfunction then this episode is for you.To connect with Dr Ajaz and LIVFIT follow these links:https://www.kch.nhs.uk/about/get-involved/groups-and-events/livfit/https://www.linkedin.com/in/saima-ajaz/?originalSubdomain=ukFurther information:https://www.journal-of-hepatology.eu/article/S0168-8278(24)00329-5/fulltextTo send us an email :[email protected]
3,472 Listeners
865 Listeners
247 Listeners
3,372 Listeners
605 Listeners
2,606 Listeners
202 Listeners
464 Listeners
2,307 Listeners
81 Listeners
127 Listeners
582 Listeners
2,051 Listeners
302 Listeners
31 Listeners